Políticas Médicas

Las políticas médicas son documentos que definen el reconocimiento de cubierta para tecnologías, procedimientos y tratamientos. Las declaraciones de necesidad médica en las políticas, sobre si una tecnología, procedimiento, tratamiento, suplido, equipo, medicamento u otro servicio mejora el resultado en la salud de la población para la cual dicha tecnología o tratamiento fue diseñado se basan en evidencia científica, estudios clínicos y opiniones profesionales de nuestros proveedores y de las organizaciones médicas reconocidas.

Cada documento desplegado en este sitio Web se provee con propósitos informativos solamente y no es una autorización, explicación de beneficios o un contrato. El recibir beneficios está sujeto a la satisfacción de todos los términos y condiciones de la cubierta. La tecnología médica cambia constantemente y nos reservamos el derecho de revisar y actualizar nuestras políticas periódicamente.

Tabla de Políticas Médicas

ID Título Revisión Descripción Acceso
11.001.033 Bone Turnover Markers For The Diagnosis And Management Of Osteoporosis And Diseases Associated With High Bone Turnover Jan 2026 Bone turnover markers are biochemical markers of either bone formation or bone resorption. commercially... Ver
11.001.034 Fecal Analysis In The Diagnosis Of Intestinal Dysbiosis Jan 2026 Intestinal dysbiosis may be defined as a state of disordered microbial ecology that is believed to cause... Ver
11.001.036 Quantitative Assay For Measurement Of Her2 Total Protein Expression And Her2 Jan 2021 Novel assays that quantitatively measure total human epidermal growth factor receptor 2 (her2) protein... Ver
11.001.037 Intracellular Micronutrient Analysis Jan 2026 Commercial laboratories offer panels of tests evaluating intracellular levels of micronutrients (essential... Ver
11.001.038 Multitarget Polymerase Chain Traction Testing For Diagnosis Of Bacterial Vaginosis Jan 2026 Bacterial vaginosis (bv) is a common medical condition resulting from an imbalance in the normal vaginal... Ver
11.001.039 Nutrient/Nutritional Panel Testing Jan 2026 Multimarker nutritional panel testing is proposed for patients with certain chronic conditions (eg, mood... Ver
11.001.040 Testing Serum Vitamin D Levels Jan 2026 Vitamin d, also known as calciferol, is a fat-soluble vitamin that has a variety of physiologic effects, most... Ver
11.001.041 Drug Testing In Pain Management And Substance Use Disorder Treatment Dec 2025 Individuals in pain management programs and substance use disorder treatment may misuse prescribed opioids... Ver
11.001.042 Fecal Calprotectin Testing Jan 2026 Calprotectin is a calcium- and zinc-binding protein that is a potential marker of intestinal inflammation.... Ver
11.001.044 Antigen Leukocyte Antibody Test Nov 2025 The antigen leukocyte antibody test (alcat) is intended to diagnose intolerance to foods and other... Ver
11.001.046 Maternal Serum Biomarkers for Prediction of Adverse Obstetric Outcomes Mar 2026 Improved accuracy of the identification of pregnant people at risk of preeclampsia and spontaneous preterm... Ver
11.001.047 Multicancer Early Detection Testing Jul 2025 Many cancers appear to have a better prognosis if diagnosed early in their natural history. this has led to... Ver
11.001.048 Urinary Test for Renal Allograft Rejection Aug 2025 Clinical assessment, routine monitoring, and noninvasive imaging of allograft function after renal transplant... Ver
11.002.001 Systems Pathology In Prostate Cancer Dec 2020 Systems pathology, an approach that combines cellular and biologic features to standard clinical parameters,... Ver
11.002.003 Molecular Testing For The Management Of Pancreatic Cysts, Barrett Esophagus, And Solid Pancreaticobiliary Lesions Dec 2024 Tests that integrate microscopic analysis with molecular tissue analysis are generally called topographic... Ver
11.002.004 Cervical Cancer Screening Technologies With Pap And Hpv Sep 2025 Data suggest that cytologic screening for cervical cancer reduces the incidence of cervical cancer by up to... Ver
11.003.001 Laboratory Tests For Heart And Kidney Transplant Rejection Feb 2026 Clinical assessment and noninvasive imaging of chronic heart failure can be limited in accurately diagnosing... Ver
11.003.002 Genetic Testing For Predisposition To Inherited Hypertrophic Cardiomyopathy Apr 2026 Familial hypertrophic cardiomyopathy is an inherited condition caused by a disease associated variant in 1 or... Ver
11.003.003 Multimarker Serum Testing Related To Ovarian Cancer Jan 2026 A variety of serum biomarkers have been studied for their association with ovarian cancer. of particular... Ver
11.003.004 Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Metastatic Colorectal Cancer (KRAS, NRAS, BRAF, MMR/MSI, HER2, and TMB) Aug 2025 The epidermal growth factor receptor (egfr) is overexpressed in colorectal cancer (crc). egfr-targeted... Ver